1-14 of 14
Keywords: Anti-vascular endothelial growth factor
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2022) 13 (3): 947–953.
Published Online: 18 November 2022
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Brolucizumab Macular neovascularization Anti-vascular endothelial growth factor Age-related macular degeneration...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2021) 11 (3): 652–657.
Published Online: 07 December 2020
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Corneal neovascularization Bevacizumab Anti-vascular endothelial growth factor Corneal neovascularization (CNV...
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2020) 11 (1): 85–91.
Published Online: 19 February 2020
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ahmed valve Anti-vascular endothelial growth factor Diabetic retinopathy Neovascular...
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2019) 10 (1): 24–31.
Published Online: 24 January 2019
... threatening. Case reports and short case series support the effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) agents (ranibizumab and bevacizumab) for CNV associated with PIC given their anti-angiogenic and anti-inflammatory effects. Evidence concerning aflibercept, a more recent...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2016) 7 (1): 1–8.
Published Online: 08 January 2016
... after anti-vascular endothelial growth factor (anti-VEGF) treatment. Methods: Fifteen eyes with ischemic CRVO-related ME were included in the study. Nine were treated with panretinal photocoagulation after initial examination. Anti-VEGF agents were injected intravitreally. Persistent ME was treated...
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2014) 5 (3): 352–356.
Published Online: 05 November 2014
.... No signs of IMT or type 3 neovascularization were detected in the right eye. Based on these findings, the patient was diagnosed with type 1 IMT and coincident type 3 neovascularization. The LE was treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Twenty-four months...
Journal Articles
Subject Area:
Ophthalmology
Case Rep Ophthalmol (2013) 4 (2): 1–6.
Published Online: 01 June 2013
.... Intravitreal anti-vascular endothelial growth factor administration is an alternative approach to CSCR management [ 10 ] which has been recently suggested. It is believed that anti-vascular endothelial growth factor exerts its effects by reducing the permeability of the choriocapillaris vessels and tightening...
Journal Articles